CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice

NCT02109250 · clinicaltrials.gov ↗

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Medullary Thyroid Cancer

Interventions

DRUG: Caprelsa

Sponsor

Genzyme, a Sanofi Company